Cargando…
Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial
While obesity increases colorectal cancer incidence, there are inconsistent results in the prognostic role of obesity or body weight change on survival. This study investigated the prognostic impact of body weight and weight change in stage III or high risk stage II colon cancer patients. We used da...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655869/ https://www.ncbi.nlm.nih.gov/pubmed/33173165 http://dx.doi.org/10.1038/s41598-020-76643-9 |
_version_ | 1783608260190797824 |
---|---|
author | Lee, Dae-Won Cho, Sooyoung Shin, Aesun Han, Sae-Won Kim, Tae-You |
author_facet | Lee, Dae-Won Cho, Sooyoung Shin, Aesun Han, Sae-Won Kim, Tae-You |
author_sort | Lee, Dae-Won |
collection | PubMed |
description | While obesity increases colorectal cancer incidence, there are inconsistent results in the prognostic role of obesity or body weight change on survival. This study investigated the prognostic impact of body weight and weight change in stage III or high risk stage II colon cancer patients. We used data from patients enrolled in the phase III AVANT trial. The AVANT trial investigated the efficacy of adding bevacizumab to standard adjuvant chemotherapy (FOFOX or XELOX). Weight change during the first 6 months of adjuvant chemotherapy was measured. Cox proportional hazard model was used to assess the prognostic influence of body weight and weight change. Among 3451 intention-to-treat population, body weight and weight change was measured in 3449 (99.9%) and 2455 (71.1%) patients, respectively. Among 2455 patients, 651 (26.5%) had weight gain over 5 kg and 179 (7.3%) had weight loss over 5 kg. Weight gain was more frequently observed in Asian and male. Neither baseline BMI nor weight change affected recurrence or survival in the Cox proportional hazard model. |
format | Online Article Text |
id | pubmed-7655869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76558692020-11-12 Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial Lee, Dae-Won Cho, Sooyoung Shin, Aesun Han, Sae-Won Kim, Tae-You Sci Rep Article While obesity increases colorectal cancer incidence, there are inconsistent results in the prognostic role of obesity or body weight change on survival. This study investigated the prognostic impact of body weight and weight change in stage III or high risk stage II colon cancer patients. We used data from patients enrolled in the phase III AVANT trial. The AVANT trial investigated the efficacy of adding bevacizumab to standard adjuvant chemotherapy (FOFOX or XELOX). Weight change during the first 6 months of adjuvant chemotherapy was measured. Cox proportional hazard model was used to assess the prognostic influence of body weight and weight change. Among 3451 intention-to-treat population, body weight and weight change was measured in 3449 (99.9%) and 2455 (71.1%) patients, respectively. Among 2455 patients, 651 (26.5%) had weight gain over 5 kg and 179 (7.3%) had weight loss over 5 kg. Weight gain was more frequently observed in Asian and male. Neither baseline BMI nor weight change affected recurrence or survival in the Cox proportional hazard model. Nature Publishing Group UK 2020-11-10 /pmc/articles/PMC7655869/ /pubmed/33173165 http://dx.doi.org/10.1038/s41598-020-76643-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lee, Dae-Won Cho, Sooyoung Shin, Aesun Han, Sae-Won Kim, Tae-You Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial |
title | Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial |
title_full | Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial |
title_fullStr | Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial |
title_full_unstemmed | Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial |
title_short | Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial |
title_sort | body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the avant trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655869/ https://www.ncbi.nlm.nih.gov/pubmed/33173165 http://dx.doi.org/10.1038/s41598-020-76643-9 |
work_keys_str_mv | AT leedaewon bodymassindexandbodyweightchangeduringadjuvantchemotherapyincoloncancerpatientsresultsfromtheavanttrial AT chosooyoung bodymassindexandbodyweightchangeduringadjuvantchemotherapyincoloncancerpatientsresultsfromtheavanttrial AT shinaesun bodymassindexandbodyweightchangeduringadjuvantchemotherapyincoloncancerpatientsresultsfromtheavanttrial AT hansaewon bodymassindexandbodyweightchangeduringadjuvantchemotherapyincoloncancerpatientsresultsfromtheavanttrial AT kimtaeyou bodymassindexandbodyweightchangeduringadjuvantchemotherapyincoloncancerpatientsresultsfromtheavanttrial |